Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 009435
Company: FRESENIUS KABI USA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NESACAINE CHLOROPROCAINE HYDROCHLORIDE 1% INJECTABLE;INJECTION Prescription None Yes Yes
NESACAINE CHLOROPROCAINE HYDROCHLORIDE 2% INJECTABLE;INJECTION Prescription AP Yes No
NESACAINE-MPF CHLOROPROCAINE HYDROCHLORIDE 2% INJECTABLE;INJECTION Discontinued None No No
NESACAINE-MPF CHLOROPROCAINE HYDROCHLORIDE 3% INJECTABLE;INJECTION Discontinued None No No
NESACAINE-MPF CHLOROPROCAINE HYDROCHLORIDE 2% INJECTABLE;INJECTION Prescription AP Yes Yes
NESACAINE-MPF CHLOROPROCAINE HYDROCHLORIDE 3% INJECTABLE;INJECTION Prescription AP Yes Yes
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/02/2018 SUPPL-44 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/009435s044lbl.pdf
02/19/2010 SUPPL-36 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009435s035s036lbl.pdf
02/19/2010 SUPPL-35 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009435s035s036lbl.pdf
06/21/2004 SUPPL-34 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/09435slr034_nesacaine_lbl.pdf

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English